4-PYRASIN-2-YLMETHYL-MORPHOLINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS

CY1125883T1Undetermined Publication Date: 2026-04-17BOEHRINGER INGELHEIM INT GMBH

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CY20231100136T
Authority / Receiving Office: CY · CY
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2018-10-17
Filing Date: 2023-03-14
Publication Date: 2026-04-17
Estimated Expiration: 2043-03-14

Application Information

Patent Timeline

17 Oct 2018

Priority

14 Mar 2023

Application

CY20231100136T

17 Apr 2026

Publication

CY1125883T1

IPC: C07D405/10; A61K31/506; A61P25/24

CPC: C07D405/10; A61P25/24; C07D413/06; A61P19/02; A61P25/18; A61P19/00; A61P25/04; A61P25/00

Inventors: GIOVANNINI Riccardo; CECI Angelo

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

AI Tagging

Technology Topics

Disease Morpholine

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to novel 4-pyrazin-2-ylmethyl morpholines of general formula A, to processes for their preparation, to pharmaceutical compositions containing them and to their use in therapy, in particular in the treatment or prevention of diseases associated with negative allosteric regulatory properties of NR2B.

Need to check novelty before this filing date? Find Prior Art